Bridgepoint agrees majority acquisition of GBA Group in deal valued at more than €1bn

Bridgepoint's agreement to buy a majority stake in GBA Group, a leading German laboratory testing company, for over €1bn highlights the firm's continued expansion in the healthcare sector. This acquisition is significant as it underscores the growing demand for laboratory services, especially in a world increasingly focused on health and diagnostics. With this deal, Bridgepoint aims to bolster GBA Group's capabilities, likely to enhance its global reach and technological advancements in testing and diagnostics.